House E&C Committee to Take Up Budget Reconciliation Bill’s Proposed PBM Accountability, Spread Pricing Provisions

The House Energy & Commerce Committee will mark up the health provisions included in the GOP-backed budget reconciliation bill Tuesday.
A key U.S. House Committee today will take up the health spending portions of a GOP-backed budget reconciliation plan, which [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Trump Signs Executive Order to Impose ‘Most-Favored Nation’ Drug Pricing Model, Unlike April EO, 340B Implications Unclear

President Donald Trump on Monday signed an executive order directing his administration Monday to establish a “most-favored nation” model for prescription drugs.
President Donald Trump directed his administration Monday to use its trade, regulatory and enforcement powers to establish a “most-favored nation” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Advocates Say 340B Providers Would be Unintended Beneficiaries in Effort to Kill Trump Proposed Medicaid Pricing Proposal

A California think tank and drug industry advocates penned new op-eds warning against the possible 340B impacts of President Donald Trump's Medicaid drug pricing proposal.
A California think tank, and an influential drug industry trade group that funds it, are raising concerns that President Donald [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Group Warns that Medicare Drug Price Negotiation Payment Process Undermines 340B

The American Hospital Association recently took issue with Biden administration IRA Medicare drug price negotiation guidance.
A key national hospital advocacy group recently urged the Trump administration to modify the retrospective payment process under the Inflation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hawley, Welch Unveil Bipartisan Senate Bill to Lower Prescription Drug Prices

U.S. Sens. Josh Hawley (R-Mo.) and Peter Welch (D-Vt.) announced the Fair Prescription Drug Prices for Americans Act on Monday.
A new bipartisan U.S. Senate proposal, backed by a key lawmaker involved in 340B policy, aims to lower the cost [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump’s FY 2026 Budget Blueprint Includes $33 Billion in HHS Cuts, No Details on 340B Plans

The White House’s Discretionary Budget Request released Friday proposes nearly $94 billion in base discretionary HHS funding—a $33.3 billion cut.
President Donald Trump’s Fiscal Year 2026 budget blueprint released Friday calls for major cuts and shakeups at the U.S. Department [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

National HIV Group Voices Concerns Over Sen. Cassidy’s 340B Probe Findings, Reform Recommendations 

Ryan White Clinics for 340B Access detailed its concerns with the legislative solutions Senate HELP Committee Chairman Bill Cassidy (R-La.) proposed in a recent report on the 340B program. 
A major national 340B provider advocacy group this week cautioned that proposed 340B reforms stemming from a high-profile GOP U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo Exempts Four More States From 340B Contract Pharmacy Restrictions, GSK Exempts Nebraska, Utah

Sumitomo Pharma America has announced exemptions to its contract pharmacy restrictions for 340B covered entities in Nebraska, North Dakota, South Dakota and Utah.
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former 340B Health, Evernorth Executives Join Walgreens 

Greg Doggett and Ben Olson, two long-time executives in the 340B world, have recently taken on key positions at retail pharmacy giant Walgreens.
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live